Yuhan Corp. (000100) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Yuhan Corp. (000100) has a cash flow conversion efficiency ratio of 0.003x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩7.70 Billion ≈ $5.22 Million USD) by net assets (₩2.36 Trillion ≈ $1.60 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 000100 net asset quality index to measure how much of total assets are equity-financed.
Yuhan Corp. - Cash Flow Conversion Efficiency Trend (2000–2025)
This chart illustrates how Yuhan Corp.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 000100 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Yuhan Corp. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Yuhan Corp. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Levima Advanced Materials Corp
SHE:003022
|
0.039x |
|
Escorts Kubota Limited
NSE:ESCORTS
|
0.040x |
|
Dajin Heavy Industry Corp
SHE:002487
|
0.158x |
|
Hilton Grand Vacations Inc
NYSE:HGV
|
0.095x |
|
Mirion Technologies Inc
NYSE:MIR
|
0.010x |
|
Shanxi Coal International Energy Group Co Ltd
SHG:600546
|
0.134x |
|
Zhejiang Huahai Pharmaceutical Co Ltd
SHG:600521
|
0.029x |
|
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
|
0.027x |
Annual Cash Flow Conversion Efficiency for Yuhan Corp. (2000–2025)
The table below shows the annual cash flow conversion efficiency of Yuhan Corp. from 2000 to 2025. For the full company profile with market capitalisation and key ratios, see 000100 market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩2.36 Trillion ≈ $1.60 Billion |
₩106.23 Billion ≈ $71.99 Million |
0.045x | +77.12% |
| 2024-12-31 | ₩2.15 Trillion ≈ $1.46 Billion |
₩54.60 Billion ≈ $37.00 Million |
0.025x | -58.25% |
| 2023-12-31 | ₩2.10 Trillion ≈ $1.42 Billion |
₩127.75 Billion ≈ $86.58 Million |
0.061x | +22.68% |
| 2022-12-31 | ₩2.01 Trillion ≈ $1.36 Billion |
₩99.53 Billion ≈ $67.45 Million |
0.050x | -3.07% |
| 2021-12-31 | ₩1.94 Trillion ≈ $1.31 Billion |
₩99.00 Billion ≈ $67.09 Million |
0.051x | +227.54% |
| 2020-12-31 | ₩1.85 Trillion ≈ $1.25 Billion |
₩28.83 Billion ≈ $19.54 Million |
0.016x | -60.96% |
| 2019-12-31 | ₩1.65 Trillion ≈ $1.12 Billion |
₩65.99 Billion ≈ $44.72 Million |
0.040x | -29.32% |
| 2018-12-31 | ₩1.65 Trillion ≈ $1.12 Billion |
₩93.45 Billion ≈ $63.33 Million |
0.057x | -27.94% |
| 2017-12-31 | ₩1.61 Trillion ≈ $1.09 Billion |
₩126.13 Billion ≈ $85.47 Million |
0.079x | +58.48% |
| 2016-12-31 | ₩1.50 Trillion ≈ $1.01 Billion |
₩74.14 Billion ≈ $50.25 Million |
0.050x | -46.47% |
| 2015-12-31 | ₩1.36 Trillion ≈ $924.32 Million |
₩126.23 Billion ≈ $85.55 Million |
0.093x | +25.11% |
| 2014-12-31 | ₩1.28 Trillion ≈ $864.64 Million |
₩94.39 Billion ≈ $63.96 Million |
0.074x | +13.89% |
| 2013-12-31 | ₩1.23 Trillion ≈ $832.36 Million |
₩79.78 Billion ≈ $54.06 Million |
0.065x | +6.63% |
| 2012-12-31 | ₩1.19 Trillion ≈ $805.24 Million |
₩72.38 Billion ≈ $49.05 Million |
0.061x | -6.02% |
| 2011-12-31 | ₩1.12 Trillion ≈ $756.79 Million |
₩72.38 Billion ≈ $49.05 Million |
0.065x | -53.52% |
| 2010-12-31 | ₩1.07 Trillion ≈ $726.97 Million |
₩149.59 Billion ≈ $101.38 Million |
0.139x | +0.42% |
| 2009-12-31 | ₩967.71 Billion ≈ $655.80 Million |
₩134.38 Billion ≈ $91.07 Million |
0.139x | -2.71% |
| 2008-12-31 | ₩862.60 Billion ≈ $584.57 Million |
₩123.12 Billion ≈ $83.43 Million |
0.143x | +10.34% |
| 2007-12-31 | ₩756.45 Billion ≈ $512.64 Million |
₩97.85 Billion ≈ $66.31 Million |
0.129x | +140.96% |
| 2006-12-31 | ₩672.40 Billion ≈ $455.68 Million |
₩36.10 Billion ≈ $24.46 Million |
0.054x | -22.35% |
| 2005-12-31 | ₩592.86 Billion ≈ $401.77 Million |
₩40.99 Billion ≈ $27.78 Million |
0.069x | +0.92% |
| 2004-12-31 | ₩519.03 Billion ≈ $351.74 Million |
₩35.56 Billion ≈ $24.10 Million |
0.069x | -4.13% |
| 2003-12-31 | ₩462.04 Billion ≈ $313.12 Million |
₩33.02 Billion ≈ $22.37 Million |
0.071x | +13.29% |
| 2002-12-31 | ₩407.93 Billion ≈ $276.45 Million |
₩25.73 Billion ≈ $17.44 Million |
0.063x | -55.91% |
| 2001-12-31 | ₩369.44 Billion ≈ $250.37 Million |
₩52.85 Billion ≈ $35.81 Million |
0.143x | +48.14% |
| 2000-12-31 | ₩323.58 Billion ≈ $219.29 Million |
₩31.24 Billion ≈ $21.17 Million |
0.097x | -- |
About Yuhan Corp.
Yuhan Corporation operates as a pharmaceutical company in South Korea and internationally. It offers manufacturing services, such as custom manufacturing; process research and development of active pharmaceutical products (APIs) and intermediates; kilo and pilot-scale production of APIs and intermediates; commercial production of APIs and intermediates; production of chemical specialties; and ana… Read more